Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

8.9K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.9K
Overview of Exosomes01:36

Overview of Exosomes

3.1K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.1K
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis01:18

Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis

2.1K
Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of two Leu-to-Pro substitutions, L57P and L43P, on structural and functional properties of cardiac tropomyosin.

The FEBS journal·2026
Same author

Proteomic and transcriptomic signatures of cytoskeletal remodeling during morphogenesis in the basal metazoan <i>Halisarca dujardinii</i> (Porifera).

Frontiers in cell and developmental biology·2026
Same author

Targeting the pMHC-TCR Interaction: Molecular Strategies and Therapeutic Potential in Autoimmunity.

International journal of molecular sciences·2026
Same author

Mining antibody functionality via AI-guided structural landscape profiling.

Nature communications·2026
Same author

Co-Immunoprecipitation-Coupled Mass Spectrometry Analysis of Zyxin's Interactome and Phosphosites in Early <i>Xenopus laevis</i> Development.

International journal of molecular sciences·2026
Same author

Characterization of <i>Bacillus velezensis</i> EV17 and K-3618 and Their Polyketide Antibiotic Oxydifficidin, an Inhibitor of Prokaryotic Translation with Low Cytotoxicity.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Nov 3, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.0K

Reprogramming Extracellular Vesicles for Protein Therapeutics Delivery.

Leyla A Ovchinnikova1, Stanislav S Terekhov1,2, Rustam H Ziganshin1

  • 1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 117997 Moscow, Russia.

Pharmaceutics
|June 2, 2021
PubMed
Summary

Engineered extracellular vesicles (EVs) efficiently deliver protein therapeutics using enveloped protein nanocages (EPNs). This system enhances drug delivery into target cells, showing great potential for medical applications.

Keywords:
EVsVSV-Genveloped virusesexosomesextracellular vesiclesmacromolecule deliverymass spectrometrynanocagesprotein delivery

More Related Videos

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

7.8K
Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.6K

Related Experiment Videos

Last Updated: Nov 3, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.0K
Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

7.8K
Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.6K

Area of Science:

  • Biotechnology
  • Cell Biology
  • Nanomedicine

Background:

  • Targeted delivery of protein therapeutics is crucial for enhancing drug efficacy.
  • Natural membrane-based systems, like extracellular vesicles (EVs), offer biocompatibility and stability for drug delivery.
  • Engineered EVs present a promising platform for overcoming delivery challenges.

Purpose of the Study:

  • To evaluate engineered, genetically encoded extracellular vesicles (EVs) for efficient protein therapeutic delivery.
  • To assess the potential of enveloped protein nanocages (EPNs) for cargo loading within EVs.
  • To investigate the therapeutic applications of engineered EVs.

Main Methods:

  • Development of a system to encapsulate enveloped protein nanocages (EPNs) within fusogenic EVs via VSV-G overexpression.
  • Utilizing bio-safe Fos-Jun heterodimerization for enhanced active cargo loading.
  • Proteomic profiling of engineered EVs to assess therapeutic potential.

Main Results:

  • Engineered EVs demonstrated efficient cargo loading and delivery into target cells.
  • Fos-Jun heterodimerization significantly increased the efficacy of active cargo loading.
  • Proteomic analysis provided a comprehensive evaluation of the engineered EVs' therapeutic potential.

Conclusions:

  • Engineered EV systems hold significant technological and biomedical potential for protein therapeutic delivery.
  • These systems can be applied in areas such as adoptive cell transfer and targeted cell reprogramming.
  • The developed platform offers a robust method for enhancing drug delivery efficiency.